Shares of WeightWatchers (WW) are climbing after the company announced a new GLP-1 medication starting at $129 as it seeks to ...

The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...

Shares of WeightWatchers (WW) are climbing after the company announced a compounded GLP-1 medication starting at $129 as it ...

The embattled diet brand said it is adding a compounded weight-loss drug in accordance with FDA rules and manufacturing ...

With the addition of compounded semaglutide [GLP-1], we are expanding our offering to include a clinical weight management ...

WW International, known as WeightWatchers, saw its stock soar on new of its new compounded GLP-1 offering. But analysts say that's only a short-term solution to its ailing business.

WW International (NASDAQ:WW), more commonly known as WeightWatchers, will now offer compounded semaglutide to its ...

WeightWatchers (WW) announced Tuesday that it is now offering off-brand weight loss drugs for one of the cheapest prices in ...

In addition to availability, the cost of weight loss drugs like Wegovy and Zepbound is a major barrier preventing many ...

After losing weight, a person’s views on body image and self-esteem often change. “Unfortunately, weight loss, particularly ...

Her tenure encompassed the exploding popularity of GLP-1 weight loss drugs, a trend Weight Watchers hoped to capitalize by acquiring subscription telehealth platform Sequence (now WeightWatchers ...